{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:22:06Z","timestamp":1792012926091,"version":"4.4.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Biomarkers are important tools for describing the adequacy or inadequacy of biological processes (to allow for the early and accurate diagnosis) and monitoring the biological effects of intervention strategies (to identify and develop optimal dose and treatment strategies). A number of lipid biomarkers are implicated in metabolic disease and the circulating levels of these biomarkers are used in clinical settings to predict and monitor disease severity. There is convincing evidence that specific circulating ceramide species can be used as biological predictors and markers of cardiovascular disease, atherosclerosis and type 2 diabetes mellitus. Here, we review the existing literature that investigated sphingolipids as biomarkers for metabolic disease prediction. What are the advantages and disadvantages? Are circulating ceramides predominantly produced in the liver? Will hepatic sphingolipid inhibitors be able to completely prevent and treat metabolic disease? As sphingolipids are being employed as biomarkers and potential metabolic disease treatments, we explore what is currently known and what still needs to be discovered.<\/jats:p>","DOI":"10.3389\/fendo.2021.684448","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T04:10:13Z","timestamp":1627359013000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?"],"prefix":"10.3389","volume":"12","author":[{"given":"Michael","family":"Mah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Febbraio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Turpin-Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2016.07.012","article-title":"Obesity Epidemiology Worldwide","volume":"45","author":"Arroyo-Johnson","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"B2","unstructured":"Obesity and Overweight Fact Sheet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans","volume":"18","author":"Wigger","year":"2017","journal-title":"Cell Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma Ceramides: A Novel Predictor of Major Adverse Cardiovascular Events After Coronary Angiography","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0320-5","article-title":"The Role of Ceramides in Metabolic Disorders: When Size and Localization Matters","volume":"16","author":"Turpin-Nolan","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00407","article-title":"Ceramides in Adipose Tissue","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00577","article-title":"The Role of Ceramides in Insulin Resistance","volume":"10","author":"Sokolowska","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00491","article-title":"Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology","volume":"11","author":"Tan-Chen","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R600010200","article-title":"When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?: Insights Into the Regulation of Ceramide Synthesis","volume":"281","author":"Pewzner-Jung","year":"2006","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.104.044529","article-title":"The 4,5-Double Bond of Ceramide Regulates Its Dipole Potential, Elastic Properties, and Packing Behavior","volume":"87","author":"Brockman","year":"2004","journal-title":"Biophys J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.34.24202","article-title":"Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-Stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated With Palmitate","volume":"274","author":"Schmitz-Peiffer","year":"1999","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212307200","article-title":"A Role for Ceramide, But Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids","volume":"278","author":"Chavez","year":"2003","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.12.031","article-title":"CerS1-Derived C18:0 Ceramide in Skeletal Muscle Promotes Obesity-Induced Insulin Resistance","volume":"26","author":"Turpin-Nolan","year":"2019","journal-title":"Cell Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molmet.2018.12.008","article-title":"The Role of C16:0 Ceramide in the Development of Obesity and Type 2 Diabetes: CerS6 Inhibition as a Novel Therapeutic Approach","volume":"21","author":"Raichur","year":"2019","journal-title":"Mol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6989","DOI":"10.1074\/jbc.M115.691212","article-title":"Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-Induced Obesity","volume":"291","author":"Gosejacob","year":"2016","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.031971","article-title":"Adult Ceramide Synthase 2 (CERS2)-Deficient Mice Exhibit Myelin Sheath Defects, Cerebellar Degeneration, and Hepatocarcinomas","volume":"284","author":"Imgrund","year":"2009","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.077594","article-title":"A Critical Role for Ceramide Synthase 2 in Liver Homeostasis: I. Alterations in Lipid Metabolic Pathways","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 Haploinsufficiency Inhibits Beta-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.305","article-title":"Schlank, a Member of the Ceramide Synthase Family Controls Growth and Body Fat in Drosophila","volume":"28","author":"Bauer","year":"2009","journal-title":"EMBO J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","article-title":"CerS6-Derived Sphingolipids Interact With Mff and Promote Mitochondrial Fragmentation in Obesity","volume":"177","author":"Hammerschmidt","year":"2019","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav3722","article-title":"Targeting a Ceramide Double Bond Improves Insulin Resistance and Hepatic Steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.077610","article-title":"A Critical Role for Ceramide Synthase 2 in Liver Homeostasis: II. Insights Into Molecular Changes Leading to Hepatopathy","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.261206","article-title":"Encephalopathy Caused by Ablation of Very Long Acyl Chain Ceramide Synthesis May Be Largely Due to Reduced Galactosylceramide Levels","volume":"286","author":"Ben-David","year":"2011","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00095.2006","article-title":"Apoptosis in Skeletal Muscle Myotubes Is Induced by Ceramides and Is Positively Related to Insulin Resistance","volume":"291","author":"Turpin","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2018-0170","article-title":"Pathological Manifestations of Farber Disease in a New Mouse Model","volume":"399","author":"Beckmann","year":"2018","journal-title":"Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.91014.2008","article-title":"Central Role of Ceramide Biosynthesis in Body Weight Regulation, Energy Metabolism, and the Metabolic Syndrome","volume":"297","author":"Yang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and Their Metabolism in Physiology and Disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000148370.60535.22","article-title":"Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E-Knockout Mice","volume":"110","author":"Park","year":"2004","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2012.191","article-title":"Plasma Sphingolipids Are Biomarkers of Metabolic Syndrome in Non-Human Primates Maintained on a Western-Style Diet","volume":"37","author":"Brozinick","year":"2013","journal-title":"Int J Obes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21448","article-title":"Skeletal Muscle and Plasma Lipidomic Signatures of Insulin Resistance and Overweight\/Obesity in Humans","volume":"24","author":"Tonks","year":"2016","journal-title":"Obes (Silver Spring)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.C088377","article-title":"The Ceramide Ratio: A Predictor of Cardiometabolic Risk","volume":"59","author":"Tippetts","year":"2018","journal-title":"J Lipid Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.570628","article-title":"Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification","volume":"11","author":"Hilvo","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and Validation of a Ceramide- and Phospholipid-Based Cardiovascular Risk Estimation Score for Coronary Artery Disease Patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12944-020-01329-0","article-title":"Association Between Ceramides and Coronary Artery Stenosis in Patients With Coronary Artery Disease","volume":"19","author":"Tu","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2017.12.005","article-title":"Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction","volume":"3","author":"de Carvalho","year":"2018","journal-title":"JACC Basic to Trans Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.08.010","article-title":"Plasma Ceramides Are Associated With Coronary Atherosclerotic Burden in Patients With ST-Segment Elevation Myocardial Infarction","volume":"320","author":"Pan","year":"2020","journal-title":"Int J Cardiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevencion Con Dieta Mediterranea)","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311927","article-title":"Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy","volume":"38","author":"Mantovani","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2019.07.006","article-title":"Associations Between Specific Plasma Ceramides and Severity of Coronary-Artery Stenosis Assessed by Coronary Angiography","volume":"46","author":"Mantovani","year":"2020","journal-title":"Diabetes Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P081281","article-title":"Plasma Concentrations of Molecular Lipid Species Predict Long-Term Clinical Outcome in Coronary Artery Disease Patients","volume":"59","author":"Anroedh","year":"2018","journal-title":"J Lipid Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma Ceramides Predict Cardiovascular Death in Patients With Stable Coronary Artery Disease and Acute Coronary Syndromes Beyond LDL-Cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2559","article-title":"Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin and PCSK9 Deficiency","volume":"99","author":"Tarasov","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.10.022","article-title":"Plasma Concentrations of Molecular Lipid Species in Relation to Coronary Plaque Characteristics and Cardiovascular Outcome: Results of the ATHEROREMO-IVUS Study","volume":"243","author":"Cheng","year":"2015","journal-title":"Atherosclerosis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.07.001","article-title":"Decreased Plasma Levels of Select Very Long Chain Ceramide Species Are Associated With the Development of Nephropathy in Type 1 Diabetes","volume":"63","author":"Klein","year":"2014","journal-title":"Metabolism"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e126925","DOI":"10.1172\/jci.insight.126925","article-title":"Large-Scale Lipidomics Identifies Associations Between Plasma Sphingolipids and T2DM Incidence","volume":"5","author":"Chew","year":"2019","journal-title":"JCI Insight"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00134.2015","article-title":"Serum Sphingolipids: Relationships to Insulin Sensitivity and Changes With Exercise in Humans","volume":"309","author":"Bergman","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1228","article-title":"Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4720-1","article-title":"Relation of Plasma Ceramides to Visceral Adiposity, Insulin Resistance and the Development of Type 2 Diabetes Mellitus: The Dallas Heart Study","volume":"61","author":"Neeland","year":"2018","journal-title":"Diabetologia"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4590-6","article-title":"Ceramide Stearic to Palmitic Acid Ratio Predicts Incident Diabetes","volume":"61","author":"Hilvo","year":"2018","journal-title":"Diabetologia"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1449","article-title":"Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study","volume":"67","author":"Lemaitre","year":"2018","journal-title":"Diabetes"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaa072","article-title":"Ceramide Biomarkers Predictive of Cardiovascular Disease Risk Increase in Healthy Older Adults After Bed Rest","volume":"75","author":"Petrocelli","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12491","article-title":"Circulating Ceramides Are Inversely Associated With Cardiorespiratory Fitness in Participants Aged 54-96 Years From the Baltimore Longitudinal Study of Aging","volume":"15","author":"Fabbri","year":"2016","journal-title":"Aging Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029617","article-title":"Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management","volume":"137","author":"Neeland","year":"2018","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2020.09.004","article-title":"Associations Between Plasma Ceramides and Mortality in Patients With Coronary Artery Disease","volume":"314","author":"Li","year":"2020","journal-title":"Atherosclerosis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.01104","article-title":"Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus","volume":"11","author":"Cao","year":"2020","journal-title":"Front Physiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1318","article-title":"Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.042028","article-title":"Liver-Specific Deficiency of Serine Palmitoyltransferase Subunit 2 Decreases Plasma Sphingomyelin and Increases Apolipoprotein E Levels","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26015","article-title":"Ablation of Very Long Acyl Chain Sphingolipids Causes Hepatic Insulin Resistance in Mice Due to Altered Detergent-Resistant Membranes","volume":"57","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.23.13834","article-title":"Sphingolipid Biosynthesis De Novo by Rat Hepatocytes in Culture. Ceramide and Sphingomyelin Are Associated With, But Not Required for, Very Low Density Lipoprotein Secretion","volume":"270","author":"Merrill","year":"1995","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0686","article-title":"Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance","volume":"62","author":"Boon","year":"2013","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.xcrm.2020.100154","article-title":"Dihydroceramides in Triglyceride-Enriched VLDL Are Associated With Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes","volume":"1","author":"Carlier","year":"2020","journal-title":"Cell Rep Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2003.08.031","article-title":"Elevation of Ceramide in Serum Lipoproteins During Acute Phase Response in Humans and Mice: Role of Serine-Palmitoyl Transferase","volume":"419","author":"Lightle","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A Ceramide-Centric View of Insulin Resistance","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab"},{"key":"B68","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","article-title":"Ceramides in Insulin Resistance and Lipotoxicity","volume":"45","author":"Summers","year":"2006","journal-title":"Prog Lipid Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1038\/s41467-018-05613-7","article-title":"A Selective Inhibitor of Ceramide Synthase 1 Reveals a Novel Role in Fat Metabolism","volume":"9","author":"Turner","year":"2018","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"16182","DOI":"10.1038\/s41598-020-73411-7","article-title":"Sphingolipid Composition of Circulating Extracellular Vesicles After Myocardial Ischemia","volume":"10","author":"Burrello","year":"2020","journal-title":"Sci Rep"},{"key":"B71","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2017.12.001","article-title":"Extracellular Vesicles Provide a Means for Tissue Crosstalk During Exercise","volume":"27","author":"Whitham","year":"2018","journal-title":"Cell Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0111","article-title":"Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity","volume":"56","author":"Kolak","year":"2007","journal-title":"Diabetes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.10.002","article-title":"Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism","volume":"24","author":"Chaurasia","year":"2016","journal-title":"Cell Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw2586","article-title":"Lipase-Independent Pathway of Lipid Release and Immune Modulation by Adipocytes","volume":"363","author":"Flaherty","year":"2019","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0216","article-title":"Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance","volume":"58","author":"Deng","year":"2009","journal-title":"Diabetes"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2017.0045","article-title":"Exosome-Like Vesicles Derived From Adipose Tissue Provide Biochemical Cues for Adipose Tissue Regeneration","volume":"23","author":"Dai","year":"2017","journal-title":"Tissue Eng Part A"},{"key":"B77","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cell.2018.09.005","article-title":"An Endothelial-To-Adipocyte Extracellular Vesicle Axis Governed by Metabolic State","volume":"175","author":"Crewe","year":"2018","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nature05414","article-title":"An Obesity-Associated Gut Microbiome With Increased Capacity for Energy Harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1194\/jlr.R052902","article-title":"Intestinal Triacylglycerol Synthesis in Fat Absorption and Systemic Energy Metabolism","volume":"56","author":"Yen","year":"2015","journal-title":"J Lipid Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jama.2013.281361","article-title":"Long-Term Drug Treatment for Obesity: A Systematic and Clinical Review","volume":"311","author":"Yanovski","year":"2014","journal-title":"JAMA"},{"key":"B81","doi-asserted-by":"publisher","first-page":"14859","DOI":"10.1038\/ncomms14859","article-title":"Pharmacological Inhibition of Adipose Triglyceride Lipase Corrects High-Fat Diet-Induced Insulin Resistance and Hepatosteatosis in Mice","volume":"8","author":"Schweiger","year":"2017","journal-title":"Nat Commun"},{"key":"B82","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis But Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12221","article-title":"Diacylglycerol Acyltransferase 1 Inhibition With AZD7687 Alters Lipid Handling and Hormone Secretion in the Gut With Intolerable Side Effects: A Randomized Clinical Trial","volume":"16","author":"Denison","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"B84","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From Sewer to Saviour - Targeting the Lymphatic System to Promote Drug Exposure and Activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M002204","article-title":"Intestinal Absorption of Dietary Maize Glucosylceramide in Lymphatic Duct Cannulated Rats","volume":"51","author":"Sugawara","year":"2010","journal-title":"J Lipid Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-015-4054-4","article-title":"Milk Phospholipids Enhance Lymphatic Absorption of Dietary Sphingomyelin in Lymph-Cannulated Rats","volume":"50","author":"Morifuji","year":"2015","journal-title":"Lipids"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M085654","article-title":"Sphingoid Bases of Dietary Ceramide 2-Aminoethylphosphonate, a Marine Sphingolipid, Absorb Into Lymph in Rats","volume":"60","author":"Tomonaga","year":"2019","journal-title":"J Lipid Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90899.2008","article-title":"Intestinal Lipid Absorption","volume":"296","author":"Iqbal","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00796","article-title":"ApoB48 as an Efficient Regulator of Intestinal Lipid Transport","volume":"11","author":"Lo","year":"2020","journal-title":"Front Physiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2011.02635.x","article-title":"Exploring the Value of Apob48 as a Marker for Atherosclerosis in Clinical Practice","volume":"42","author":"Alipour","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"52389","DOI":"10.3791\/52389","article-title":"The Mesenteric Lymph Duct Cannulated Rat Model: Application to the Assessment of Intestinal Lymphatic Drug Transport","author":"Trevaskis","year":"2015","journal-title":"J Vis Exp"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0663","article-title":"An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice","volume":"66","author":"Xie","year":"2017","journal-title":"Diabetes"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.684448\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T04:10:15Z","timestamp":1627359015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.684448\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":92,"alternative-id":["10.3389\/fendo.2021.684448"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.684448","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"article-number":"684448"}}